Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Mar-Apr;64(2):129-135.
doi: 10.4103/ijd.IJD_240_17.

Combination of Hydroquinone and Fractional CO2 Laser versus Hydroquinone Monotherapy in Melasma Treatment: A Randomized, Single-blinded, Split-face Clinical Trial

Sanaz Nourmohammadi Abadchi  1 , Farahnaz Fatemi Naeini  1 , Elham Beheshtian  1
Affiliations

Combination of Hydroquinone and Fractional CO2 Laser versus Hydroquinone Monotherapy in Melasma Treatment: A Randomized, Single-blinded, Split-face Clinical Trial

Sanaz Nourmohammadi Abadchi et al. Indian J Dermatol. 2019 Mar-Apr.

Abstract

Background: Melasma is a chronic hyperpigmentation skin disorder mainly affecting women in the reproductive age. Available treatments for melasma do not lead to long-term satisfactory results.

Aims: This study aimed to compare the efficacy of fractional CO2 laser in combination with topical therapy to topical therapy alone.

Materials and methods: Forty women with bilateral melasma were studied in this randomized single-blinded clinical trial. Each side of the face was randomly allotted to either topical hydroquinone 4% or combination of topical hydroquinone 4% and fractional CO2 laser. Patients received three sessions of laser therapy at 3-week intervals. Hydroquinone 4% application on both sides maintained for 3 months after the last laser session. The clinical improvement (darkness [D] and homogeneity [H] of hyperpigmentation) was measured by a blinded main investigator and an outcome assessor. Furthermore, improvement was assessed by physician's global assessment (PGA) and patient satisfaction (visual analog scale [VAS] score).

Results: Significant reduction in D observed 3 weeks after combination therapy (P<0.001) and 6 weeks after monotherapy (P<0.001). Reduction in H became significant after 6 weeks in both groups (P<0.001). However, the two methods were not considerably different in any session (P>0.05). Furthermore, control and experiment sides were not significantly different considering VAS score and PGA (P>0.05).

Conclusion: Considering the short-term outcome of laser and hydroquinone therapy, we can apply it to obtain earlier positive results. However, because of the lack of significant difference between the two methods and also the high cost of laser therapy, it seems better not to recommend fractional CO2 laser to patients as adjunctive therapy for long-term treatment of melasma.

Keywords: Fractional CO2 laser; hydroquinone; melasma.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
Consort diagram of studied population
Figure 2
Figure 2
Physician visual analog scale on the experiment and control sides. (H: Hydroquinone, H + L: Hydroquinone + Laser)
Figure 3
Figure 3
Changes in the visual analog scale scores before and after the treatments (95% confidence interval plot)
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Handel AC, Miot LD, Miot HA. Melasma: A clinical and epidemiological review. An Bras Dermatol. 2014;89:771–82. - PMC - PubMed
    1. Sheth VM, Pandya AG. Melasma: A comprehensive update: Part I. J Am Acad Dermatol. 2011;65:689–97. - PubMed
    1. Sarkar R, Arora P, Garg VK, Sonthalia S, Gokhale N. Melasma update. Indian Dermatol Online J. 2014;5:426–35. - PMC - PubMed
    1. Bandyopadhyay D. Topical treatment of melasma. Indian J Dermatol. 2009;54:303–9. - PMC - PubMed
    1. Mandry Pagán R, Sánchez JL. Mandibular melasma. P R Health Sci J. 2000;19:231–4. - PubMed